Stay updated with breaking news from Daverage Risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, Feb. 2, 2022 /PRNewswire/ -- Lument Finance Trust, Inc. (NYSE: LFT) ('we', 'LFT' or 'the Company') today announced preliminary, unaudite...
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced performance data for a second-generation Cologuard (multi-target stool DNA) test showing...
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced performance data for a second-generation Cologuard (multi-target stool DNA) test showing...
Columbia University Irving Medical Center Cervical cancer screening tests-Pap smears and HPV tests-are frequently overused among commercially insured women with average risk of developing cancer, a new study from researchers at Columbia University’s Vagelos College of Physicians and Surgeons and Herbert Irving Comprehensive Cancer Center finds. Jason Wright The study, involving nearly 2 million women who were screened for cervical cancer between 2013 and 2014, found that nearly two-thirds received unnecessary tests in the next three years, before their next recommended screening. “If the...